HEADER HYDROLASE 14-MAR-10 2X91 TITLE CRYSTAL STRUCTURE OF ANCE-LISINOPRIL COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANGIOTENSIN CONVERTING ENZYME; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 17-614; COMPND 5 SYNONYM: DIPEPTIDYL CARBOXYPEPTIDASE I, KININASE II; COMPND 6 EC: 3.4.15.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: DROSOPHILA MELANOGASTER; SOURCE 3 ORGANISM_COMMON: FRUIT FLY; SOURCE 4 ORGANISM_TAXID: 7227; SOURCE 5 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 644223; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: GS115; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PPIC9 KEYWDS HYDROLASE, ACE INHIBITOR, ZINC METALLOPEPTIDASE EXPDTA X-RAY DIFFRACTION AUTHOR M.AKIF,D.GEORGIADIS,A.MAHAJAN,V.DIVE,E.D.STURROCK,R.E.ISAAC, AUTHOR 2 K.R.ACHARYA REVDAT 5 06-NOV-24 2X91 1 HETSYN REVDAT 4 29-JUL-20 2X91 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE ATOM REVDAT 3 16-MAR-11 2X91 1 SOURCE KEYWDS REMARK REVDAT 2 21-JUL-10 2X91 1 JRNL ATOM REVDAT 1 02-JUN-10 2X91 0 JRNL AUTH M.AKIF,D.GEORGIADIS,A.MAHAJAN,V.DIVE,E.D.STURROCK,R.E.ISAAC, JRNL AUTH 2 K.R.ACHARYA JRNL TITL HIGH RESOLUTION CRYSTAL STRUCTURES OF DROSOPHILA JRNL TITL 2 MELANOGASTER ANGIOTENSIN CONVERTING ENZYME IN COMPLEX WITH JRNL TITL 3 NOVEL INHIBITORS AND ANTI- HYPERTENSIVE DRUGS. JRNL REF J.MOL.BIOL. V. 400 502 2010 JRNL REFN ISSN 0022-2836 JRNL PMID 20488190 JRNL DOI 10.1016/J.JMB.2010.05.024 REMARK 2 REMARK 2 RESOLUTION. 1.98 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0072 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.98 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.78 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 93.6 REMARK 3 NUMBER OF REFLECTIONS : 70554 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.209 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3703 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.98 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.03 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4856 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 87.11 REMARK 3 BIN R VALUE (WORKING SET) : 0.2780 REMARK 3 BIN FREE R VALUE SET COUNT : 253 REMARK 3 BIN FREE R VALUE : 0.3120 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4853 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 175 REMARK 3 SOLVENT ATOMS : 431 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.73 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.133 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.120 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.085 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.038 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.955 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.948 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5186 ; 0.007 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7039 ; 0.976 ; 1.979 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 598 ; 4.844 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 263 ;34.562 ;24.677 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 856 ;12.510 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 25 ;14.832 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 749 ; 0.072 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3944 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2978 ; 0.343 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4798 ; 0.683 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2208 ; 1.057 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2239 ; 1.815 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2X91 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-MAR-10. REMARK 100 THE DEPOSITION ID IS D_1290043250. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-JAN-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9763 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 79396 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.980 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.6 REMARK 200 DATA REDUNDANCY : 2.500 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.98 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.6 REMARK 200 DATA REDUNDANCY IN SHELL : 2.50 REMARK 200 R MERGE FOR SHELL (I) : 0.30000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 67.73 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.84 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: H 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 X+2/3,Y+1/3,Z+1/3 REMARK 290 5555 -Y+2/3,X-Y+1/3,Z+1/3 REMARK 290 6555 -X+Y+2/3,-X+1/3,Z+1/3 REMARK 290 7555 X+1/3,Y+2/3,Z+2/3 REMARK 290 8555 -Y+1/3,X-Y+2/3,Z+2/3 REMARK 290 9555 -X+Y+1/3,-X+2/3,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 86.40350 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 49.88508 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 34.17300 REMARK 290 SMTRY1 5 -0.500000 -0.866025 0.000000 86.40350 REMARK 290 SMTRY2 5 0.866025 -0.500000 0.000000 49.88508 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 34.17300 REMARK 290 SMTRY1 6 -0.500000 0.866025 0.000000 86.40350 REMARK 290 SMTRY2 6 -0.866025 -0.500000 0.000000 49.88508 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 34.17300 REMARK 290 SMTRY1 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 99.77017 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 68.34600 REMARK 290 SMTRY1 8 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 8 0.866025 -0.500000 0.000000 99.77017 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 68.34600 REMARK 290 SMTRY1 9 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 -0.500000 0.000000 99.77017 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 68.34600 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 17 REMARK 465 LEU A 18 REMARK 465 VAL A 19 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 20 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN A 311 C2 NAG A 1625 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 53 82.13 -166.83 REMARK 500 ASP A 210 110.99 -163.55 REMARK 500 LEU A 345 -130.52 -102.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2018 DISTANCE = 6.54 ANGSTROMS REMARK 525 HOH A2027 DISTANCE = 6.22 ANGSTROMS REMARK 525 HOH A2038 DISTANCE = 6.94 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1619 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 367 NE2 REMARK 620 2 HIS A 371 NE2 107.6 REMARK 620 3 GLU A 395 OE1 95.9 102.3 REMARK 620 4 LPR A1615 O2 115.2 130.7 96.6 REMARK 620 5 LPR A1615 O3 96.7 97.0 152.6 56.0 REMARK 620 N 1 2 3 4 REMARK 630 REMARK 630 MOLECULE TYPE: OLIGOPEPTIDE ENZYME INHIBITOR REMARK 630 MOLECULE NAME: [N2-[(S)-1-CARBOXY-3-PHENYLPROPYL]-L-LYSYL-L-PROLINE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 LPR A 1615 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: CLT LYS PRO REMARK 630 DETAILS: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1J38 RELATED DB: PDB REMARK 900 RIBONUCLEOTIDE REDUCTASE Y730NO2Y AND Y731A MODIFIED R1 SUBUNIT OF REMARK 900 E. COLI REMARK 900 RELATED ID: 1J36 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE FIRST PDZ DOMAIN OF HUMAN SCRIB1 REMARK 900 RELATED ID: 1J37 RELATED DB: PDB REMARK 900 HUMAN CARBONIC ANHYDRASE II IN COMPLEX WITH NOVEL INHIBITORS REMARK 900 RELATED ID: 2X94 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ANCE-PERINDOPRILAT COMPLEX REMARK 900 RELATED ID: 2X8Z RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ANCE-CAPTOPRIL COMPLEX REMARK 900 RELATED ID: 2X8Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ANCE REMARK 900 RELATED ID: 2X95 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ANCE-LISINOPRIL- TRYPTOPHAN ANALOGUE, LISW-S REMARK 900 COMPLEX REMARK 900 RELATED ID: 2X92 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ANCE-RAMIPRILAT COMPLEX REMARK 900 RELATED ID: 2X96 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ANCE-RXPA380 COMPLEX REMARK 900 RELATED ID: 2X97 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ANCE-RXP407 COMPLEX REMARK 900 RELATED ID: 2X93 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ANCE-TRANDOLAPRILAT COMPLEX REMARK 900 RELATED ID: 2X90 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ANCE-ENALAPRILAT COMPLEX DBREF 2X91 A 17 614 UNP Q10714 ACE_DROME 17 614 SEQRES 1 A 598 ALA LEU VAL LYS GLU GLU ILE GLN ALA LYS GLU TYR LEU SEQRES 2 A 598 GLU ASN LEU ASN LYS GLU LEU ALA LYS ARG THR ASN VAL SEQRES 3 A 598 GLU THR GLU ALA ALA TRP ALA TYR GLY SER ASN ILE THR SEQRES 4 A 598 ASP GLU ASN GLU LYS LYS LYS ASN GLU ILE SER ALA GLU SEQRES 5 A 598 LEU ALA LYS PHE MET LYS GLU VAL ALA SER ASP THR THR SEQRES 6 A 598 LYS PHE GLN TRP ARG SER TYR GLN SER GLU ASP LEU LYS SEQRES 7 A 598 ARG GLN PHE LYS ALA LEU THR LYS LEU GLY TYR ALA ALA SEQRES 8 A 598 LEU PRO GLU ASP ASP TYR ALA GLU LEU LEU ASP THR LEU SEQRES 9 A 598 SER ALA MET GLU SER ASN PHE ALA LYS VAL LYS VAL CYS SEQRES 10 A 598 ASP TYR LYS ASP SER THR LYS CYS ASP LEU ALA LEU ASP SEQRES 11 A 598 PRO GLU ILE GLU GLU VAL ILE SER LYS SER ARG ASP HIS SEQRES 12 A 598 GLU GLU LEU ALA TYR TYR TRP ARG GLU PHE TYR ASP LYS SEQRES 13 A 598 ALA GLY THR ALA VAL ARG SER GLN PHE GLU ARG TYR VAL SEQRES 14 A 598 GLU LEU ASN THR LYS ALA ALA LYS LEU ASN ASN PHE THR SEQRES 15 A 598 SER GLY ALA GLU ALA TRP LEU ASP GLU TYR GLU ASP ASP SEQRES 16 A 598 THR PHE GLU GLN GLN LEU GLU ASP ILE PHE ALA ASP ILE SEQRES 17 A 598 ARG PRO LEU TYR GLN GLN ILE HIS GLY TYR VAL ARG PHE SEQRES 18 A 598 ARG LEU ARG LYS HIS TYR GLY ASP ALA VAL VAL SER GLU SEQRES 19 A 598 THR GLY PRO ILE PRO MET HIS LEU LEU GLY ASN MET TRP SEQRES 20 A 598 ALA GLN GLN TRP SER GLU ILE ALA ASP ILE VAL SER PRO SEQRES 21 A 598 PHE PRO GLU LYS PRO LEU VAL ASP VAL SER ALA GLU MET SEQRES 22 A 598 GLU LYS GLN GLY TYR THR PRO LEU LYS MET PHE GLN MET SEQRES 23 A 598 GLY ASP ASP PHE PHE THR SER MET ASN LEU THR LYS LEU SEQRES 24 A 598 PRO GLN ASP PHE TRP ASP LYS SER ILE ILE GLU LYS PRO SEQRES 25 A 598 THR ASP GLY ARG ASP LEU VAL CYS HIS ALA SER ALA TRP SEQRES 26 A 598 ASP PHE TYR LEU THR ASP ASP VAL ARG ILE LYS GLN CYS SEQRES 27 A 598 THR ARG VAL THR GLN ASP GLN LEU PHE THR VAL HIS HIS SEQRES 28 A 598 GLU LEU GLY HIS ILE GLN TYR PHE LEU GLN TYR GLN HIS SEQRES 29 A 598 GLN PRO PHE VAL TYR ARG THR GLY ALA ASN PRO GLY PHE SEQRES 30 A 598 HIS GLU ALA VAL GLY ASP VAL LEU SER LEU SER VAL SER SEQRES 31 A 598 THR PRO LYS HIS LEU GLU LYS ILE GLY LEU LEU LYS ASP SEQRES 32 A 598 TYR VAL ARG ASP ASP GLU ALA ARG ILE ASN GLN LEU PHE SEQRES 33 A 598 LEU THR ALA LEU ASP LYS ILE VAL PHE LEU PRO PHE ALA SEQRES 34 A 598 PHE THR MET ASP LYS TYR ARG TRP SER LEU PHE ARG GLY SEQRES 35 A 598 GLU VAL ASP LYS ALA ASN TRP ASN CYS ALA PHE TRP LYS SEQRES 36 A 598 LEU ARG ASP GLU TYR SER GLY ILE GLU PRO PRO VAL VAL SEQRES 37 A 598 ARG SER GLU LYS ASP PHE ASP ALA PRO ALA LYS TYR HIS SEQRES 38 A 598 ILE SER ALA ASP VAL GLU TYR LEU ARG TYR LEU VAL SER SEQRES 39 A 598 PHE ILE ILE GLN PHE GLN PHE TYR LYS SER ALA CYS ILE SEQRES 40 A 598 LYS ALA GLY GLN TYR ASP PRO ASP ASN VAL GLU LEU PRO SEQRES 41 A 598 LEU ASP ASN CYS ASP ILE TYR GLY SER ALA ALA ALA GLY SEQRES 42 A 598 ALA ALA PHE HIS ASN MET LEU SER MET GLY ALA SER LYS SEQRES 43 A 598 PRO TRP PRO ASP ALA LEU GLU ALA PHE ASN GLY GLU ARG SEQRES 44 A 598 ILE MET SER GLY LYS ALA ILE ALA GLU TYR PHE GLU PRO SEQRES 45 A 598 LEU ARG VAL TRP LEU GLU ALA GLU ASN ILE LYS ASN ASN SEQRES 46 A 598 VAL HIS ILE GLY TRP THR THR SER ASN LYS CYS VAL SER MODRES 2X91 ASN A 53 ASN GLYCOSYLATION SITE MODRES 2X91 ASN A 196 ASN GLYCOSYLATION SITE MODRES 2X91 ASN A 311 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NAG B 2 14 HET BMA B 3 11 HET MAN B 4 11 HET BMA B 5 11 HET MAN B 6 11 HET LPR A1615 29 HET EPE A1616 15 HET EPE A1617 15 HET EPE A1618 15 HET ZN A1619 1 HET NAG A1625 14 HET NAG A1626 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM LPR [N2-[(S)-1-CARBOXY-3-PHENYLPROPYL]-L-LYSYL-L-PROLINE HETNAM EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID HETNAM ZN ZINC ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN LPR LISINOPRIL HETSYN EPE HEPES FORMUL 2 NAG 4(C8 H15 N O6) FORMUL 2 BMA 2(C6 H12 O6) FORMUL 2 MAN 2(C6 H12 O6) FORMUL 3 LPR C21 H31 N3 O5 FORMUL 4 EPE 3(C8 H18 N2 O4 S) FORMUL 7 ZN ZN 2+ FORMUL 10 HOH *431(H2 O) HELIX 1 1 LYS A 20 SER A 52 1 33 HELIX 2 2 THR A 55 THR A 81 1 27 HELIX 3 3 GLN A 84 TYR A 88 5 5 HELIX 4 4 SER A 90 LYS A 102 1 13 HELIX 5 5 LEU A 103 LEU A 108 5 6 HELIX 6 6 PRO A 109 LYS A 129 1 21 HELIX 7 7 PRO A 147 SER A 156 1 10 HELIX 8 8 ASP A 158 GLY A 174 1 17 HELIX 9 9 VAL A 177 ASN A 195 1 19 HELIX 10 10 SER A 199 ASP A 206 1 8 HELIX 11 11 GLU A 207 GLU A 209 5 3 HELIX 12 12 THR A 212 GLY A 244 1 33 HELIX 13 13 HIS A 257 LEU A 259 5 3 HELIX 14 14 TRP A 267 GLU A 269 5 3 HELIX 15 15 ILE A 270 SER A 275 1 6 HELIX 16 16 VAL A 285 GLN A 292 1 8 HELIX 17 17 THR A 295 MET A 310 1 16 HELIX 18 18 PRO A 316 SER A 323 1 8 HELIX 19 19 THR A 358 GLN A 379 1 22 HELIX 20 20 PRO A 382 ARG A 386 5 5 HELIX 21 21 ASN A 390 SER A 406 1 17 HELIX 22 22 THR A 407 ILE A 414 1 8 HELIX 23 23 ASP A 423 ILE A 439 1 17 HELIX 24 24 VAL A 440 ARG A 457 1 18 HELIX 25 25 ASP A 461 ALA A 463 5 3 HELIX 26 26 ASN A 464 GLY A 478 1 15 HELIX 27 27 ASP A 491 ALA A 494 5 4 HELIX 28 28 LYS A 495 ALA A 500 1 6 HELIX 29 29 TYR A 504 ALA A 525 1 22 HELIX 30 30 PRO A 536 CYS A 540 5 5 HELIX 31 31 SER A 545 SER A 557 1 13 HELIX 32 32 PRO A 563 GLY A 573 1 11 HELIX 33 33 GLY A 579 ASN A 600 1 22 SHEET 1 AA 2 ILE A 254 PRO A 255 0 SHEET 2 AA 2 ILE A 479 GLU A 480 1 N GLU A 480 O ILE A 254 SHEET 1 AB 2 SER A 339 ASP A 342 0 SHEET 2 AB 2 VAL A 349 LYS A 352 -1 O ARG A 350 N TRP A 341 SHEET 1 AC 2 ARG A 485 SER A 486 0 SHEET 2 AC 2 CYS A 612 VAL A 613 1 N VAL A 613 O ARG A 485 SSBOND 1 CYS A 133 CYS A 141 1555 1555 2.04 SSBOND 2 CYS A 336 CYS A 354 1555 1555 2.04 SSBOND 3 CYS A 467 CYS A 612 1555 1555 2.06 SSBOND 4 CYS A 522 CYS A 540 1555 1555 2.02 LINK ND2 ASN A 53 C1 NAG A1626 1555 1555 1.41 LINK ND2 ASN A 196 C1 NAG B 1 1555 1555 1.44 LINK ND2 ASN A 311 C1 NAG A1625 1555 1555 1.44 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.45 LINK O4 NAG B 2 C1 BMA B 3 1555 1555 1.45 LINK O3 BMA B 3 C1 MAN B 4 1555 1555 1.45 LINK O6 BMA B 3 C1 MAN B 6 1555 1555 1.44 LINK O6 MAN B 4 C1 BMA B 5 1555 1555 1.44 LINK NE2 HIS A 367 ZN ZN A1619 1555 1555 2.05 LINK NE2 HIS A 371 ZN ZN A1619 1555 1555 2.03 LINK OE1 GLU A 395 ZN ZN A1619 1555 1555 1.96 LINK O2 LPR A1615 ZN ZN A1619 1555 1555 1.90 LINK O3 LPR A1615 ZN ZN A1619 1555 1555 2.59 CISPEP 1 ASP A 146 PRO A 147 0 4.18 CRYST1 172.807 172.807 102.519 90.00 90.00 120.00 H 3 9 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005787 0.003341 0.000000 0.00000 SCALE2 0.000000 0.006682 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009754 0.00000